Introduction
Bacteroides fragilis is considered to be the most virulent species in the genus Bacteroides because of its virulence factors and its predominance among isolates from infections, despite its presence as only a small component of the normal intestinal microflora [ 11. Adhesion properties, demonstrated in assays of haemagglutination and adherence to cell cultures, have been related to virulence. Surface structures such as the polysaccharide capsule [2, 3] , fimbriae [4] , microcapsule and outer membrane non-fimbrial proteins [5] have been linked with adhesion to host cells, but without precise definition of the mechanisms. B. fragilis also produces an enterotoxin that causes diarrhoea in animals [6] and has been associated with diarrhoea in man [7] . The toxin has been purified and characterised as a zinc-metalloprotease [8] , with activity against tight junction proteins, disrupting the intestinal epithelial barrier [9] . Its activity has been linked with diarrhoea and fluid loss, and also to bacterial translocation from the intestinal environment. Some authors have des-cribed toxin expression in strains isolated from nonintestinal infections [lo] . This protease has now been named fragilysin and is encoded by the bft gene. In the present study, B. fragilis isolates from different origins were compared with clinical isolates in relation to their adhesive properties, the presence of the bft gene and fragilysin production, with the aim of detecting in vitro possible virulence markers for the species.
Materials and methods

Bacterial isolates and culture conditions
Fifty-eight isolates of B. fragilis from different origins were analysed. They were isolated from human nonintestinal infections (20) , human intestinal microflora (14) , animal intestinal microflora ( 5 ) and polluted aquatic environment (I 1). Four human intestinal isolates, previously defined as enterotoxigenic (078320 and 079298-3) and non-enterotoxigenic (283-2-1 and 077225-2) and two animal intestinal isolates (Bdl and 865193-4), given by Dr Lyle Myers (Montana University, USA) were included. Two reference strains obtained from the American Type Culture Collection, Rockville, MD, USA (ATCC 25285 and ATCC 23745) were also studied. One Escherichia coli LT-producing strain (40 T), given by Dr Beatriz Guth (Escola Paulista de Medicina, SZo Paulo, Brazil) was used as positive control in rabbit intestinal ligated loop assays. Isolation and identification were performed by conventional methods, with PRAS medium [ I l l and the strains were stored in skim-milk 10% at -20°C.
Haemagglutination and auto-agglutination assays
Organisms grown in BHI-PRAS [ 1 I] for 18 h at 37°C were pelleted by centrifugation, washed and resuspended in 0.01 M phosphate-buffered saline (PBS) pH 7.2, to a concentration of c. 3.0 X 10'' cfu/ml. Fifty pl of the bacterial suspension were serially diluted in two-fold series in a microtitration tray and 50 pl of the human A+ erythrocyte suspension (1%) were added to each well, except in one, for the autoagglutination assay. The microtitration tray was shaken gently for 1 min at room temperature and then was read after incubation at 4°C for 60 min. An extra incubation, overnight at 4"C, was also done. Haemagglutination activity (HA) titres were expressed as the highest bacterial dilution that showed haemagglutination activity. The auto-agglutination activity (AA) was evaluated in a scale ranging from 1 + to 4+ [ 121.
Haemagglutination and auto-agglutination in hibition assays
The haemagglutination and auto-agglutination assays were done as described above, with untreated suspensions as controls and test suspension treated as follows. The bacterial suspension were heated at 100°C for 30min and 80°C for 1 h. Assays were done with the addition of 50 pl of a 2.5 mM EDTA solution, pH 7.8, to each well. Pelleted cells were resuspended in 1 ml of trypsin (Gibco-BRL) 2 mg/ml solution, pH 7.8, incubated with shaking at 37°C for 45 min, centrifbged and resuspended in PBS. After further Centrifugation, pelleted cells were resuspended in bovine serum albumin (BSA; Sigma) 5 mg/ml in PBS.
HT29 cell culture
HT29 cells were grown in culture flasks in Dulbecco's medium with glutamine, supplemented with penicillin 100 IU/ml, streptomycin 100 pg/ml and fetal bovine serum 10% (hereafter referred to as medium), at 37°C in air with C02 5%. Cells were transferred to fresh medium twice a week.
Adherence to HT29 cells
Radiolabelled bacteria were prepared by growth in 5 ml of BHI-PRAS containing S35 methionine (1 00 pCi/ml). The cultures were incubated anaerobically for 24 h at 37°C. HT29 cell-culture monolayers were prepared in Falcon multiwell trays (2 cm2 wells). Confluent cell layers were washed twice with PBS immediately before use. Radiolabelled bacteria were washed three times with PBS and resuspended to ODs50 0.4 ( lo9 bacteria/ml). Bacterial suspension (0.5 ml) was added to each of the monolayers. Trays were shaken on a plate shaker for 150 min at room temperature. The unbound bacteria were removed by washing the cells three times with PBS; finally, PBS (0.5 ml) was added to each well. All cells were lysed with 1.5 ml of sodium dodecyl sulphate (SDS) 5.5% w/v Overnight at room temperature. The amount of radioactivity was determined by liquid scintillation counting. The radioactivity bound in the assay was compared with the total count in unwashed cells to give a percentage adherence value [3] .
Inhibition of adherence assays
The reference strain ATCC 25285 was radiolabelled and treated with heat, trypsin and EDTA as described above in the haemagglutination inhibition assays. The adherence assay was done with and untreated suspension as control.
Hydrophobicity level
Organisms were grown in BHI-PRAS [ 111 for 18 h at 37°C and then washed three times with PBS and resuspended to OD660 0.4. Xylene 1:2.5 (v:v) was added to the bacterial suspension, shaken in a 'vortex' mixer for 2 min, and then kept at room temperature for 20 min. The OD660 of the lower phase was determined. The hydrophobicity level (HL) was calculated from the formula:
The isolates with percentages > 50% were considered hydrophobic.
Fragilysin activity
Organisms were grown overnight in BHI-PRAS at 37°C. The cultures were centrifuged at 4000 g for 10 min and the supernates were frozen immediately and kept at -20°C until used. HT29 cells from one flask were resuspended in 20 ml of medium, distributed into a 96-well microtitration plate (200 pl/well) and allowed to grow for 2-3 days. Before the assay the medium was removed and 180 pl of fresh medium without serum were added to each well: 20 pl of bacterial culture supernates were inoculated into the wells in quadruplicate. The plate was incubated at 37°C in air with C02 5% and then examinated after 2 and 4 h. The culture supernates were considered to contain fragilysin if a cytopathic effect was visible [14] .
Enterotoxin activity in the ligated intestinal loop assay B. fragilis supernates from cultures in log phase (HT29+ and -) were injected into loops in the proximal ileum of adult rabbits, which were then killed after 18 h and examined for the secretory response in the ligated loops. Sterile BHI and PBS were used as negative controls and the E. coli strain 40T (LT+) as a positive control [ 151.
Detection of fragilysin gene (bfi)
Pure genomic DNA from all strains tested was obtained by a standard miniprep procedure [ 161. The concentration of DNA in the samples was determined by spectrophotometry with the GenQuant apparatus (Pharmacia). PCR was used to obtain the DNA fragment of the bft gene, with the specific primers: 5'-TGTGGAATCA-CATCGTGCATCA-3' and 5 '-AGTTCGCCGCAT-CCTGCATCTG-3 ' (Gibco-BE). PCR was performed with Taq polymerase 1.25 U (Gibco-BRL) in 50 ,ul containing chromosomal DNA (50 ng), primers (80 pmol), deoxynucleoside triphosphates (200 ,UM) and 1.5 mM MgC12. The amplification cycle was denaturation at 94°C for 1 min, annealing at 66°C for 2 min and extension at 72°C for 5 min [17] . The amplified product was analysed by agarose gel electrophoresis.
Results
Different adhesion patterns were detected in the haemagglutination and auto-agglutination assays with the 58 isolates (Tables 1 and 2 ): HAf AA-strains (18 isolates), HAf AA+ strains (1 3), HA-AAf strains (1) and HA-AA-strains (26). However, when BSA was used in the inhibition tests, these patterns were altered, as in many cases the inhibition of AA determined the loss of HA (strains 1103-4 and 11 18-1 in Table 1 and strains 0783220 and Bdl in Table 2 ). Based on these results the groups were re-arranged: HA+ AA-strains (IS), HAt AA+ strains (9), HA-AAS strains (1) and HA-AA-strains (30). Treatment with trypsin, heat and EDTA inhibited HA and AA of all strains. In the assays for determination of surface hydrophobicity, 15 of 22 isolates from non-intestinal infections were defined as hydrophobic and seven as hydrophilic (Table 1 ). In the group of 36 isolates from intestinal infections, intestinal microflora and from polluted aquatic environment 22 isolates were defined as hydrophobic and 14 as hydrophilic (Table 2) .
When a selected group of nine isolates from different sources, without AA and with different HA titres, was assayed with HT29 cells, the percentage of adherence ranged from 7.7% to 30% ( Table 3 ). The number of adhering bacteria/cell was calculated for each isolate and isolates with < 150 bacteria/cell were considered poorly adherent (0), moderately adherent isolates (3) had 150-300 bacteria/cell and highly adherent strains (6) had >300 bacteria/cell. Treatment with trypsin, heat and EDTA inhibited the cell adhesion capacity of strain ATCC 25285.
In all 58 isolates analysed, it was possible to verifL that only two isolates originating fiom diarrhoea samples (strains 078320 and 079298-3) were able to express fragilysin in assays with HT29 cells, causing rounded cells after incubation for 2-4 h. The other isolates analysed originated from non-intestinal infections, human intestinal microflora, animal intestinal microflora, polluted aquatic environment, animal intestinal infections and also human intestinal infections (strains 283-2-1 and 077225-2) did not show cytotoxicity to HT29 cells. The supernates of strains 078320 and 079298-3 were serially diluted in Dulbecco's medium HA, SH, see footnote to Table 1 . *percentage adherence, difference between total radioactivity in the inoculum added and radioactivity bound in the assay. +number of bacteria/cell, calculated from estimated number of cells/well (2 X lo5 in 2 cm') and the bacterial inoculum (1 X lo8), related to the percentage adherence. 'ATCC reference strain. $From chronic otitis media.
11 From intra-abdominal infection. 'Non-enterotoxigenic strain. Enterotoxigenic strains.
** without fetal serum, and the cytotoxic titres were 8 and 128, respectively ( Table 4 ).
The enterotoxic activity of fragilysin was also confirmed in the rabbit intestinal ligated loop assay when the supernates of the cytotoxic strains were assayed.
The presence of the fragilysin gene was confirmed by PCR with specific primers for the bft gene; all 58 strains were assayed and 900-bp bands in agarose gel electrophoresis were found only in the cytotoxic strains 078320 and 079298-3 ( Fig. 1) .
Discussion
In this study, the HA technique was used to characterise the adherence properties of isolates, considered to represent the factor that may contribute to the prevalence of B. fragilis in infections. between bacteria and other surfaces has been proposed [19] . In the present study, HA was totally inhibited by physicochemical treatments, suggesting that the haemagglutinins present have a proteic nature and an activity dependent on metallic ions. Bovine serum albumin was capable of inhibiting AA and HA in the isolates studied; however, hydrophobicity and the origins of isolates do not seem to be related to AA and HA.
Adherence by B. fragilis has also been analysed in other cell culture systems. Oyston and Handley [3] verified lower levels of adhesion of buccal epithelial cells than to intestinal epithelial HT29 cells. In testing the adherence of B. fragilis to HT29 cells, it was verified that isolates with higher titres of HA were less adherent to the cells, which could suggest the existence of different molecules responsible for the two features. Thus, HA determination was not satisfactory as a selection criterion for isolates adherent to intestinal epithelial cells (HT29). Treatment with heat, trypsin and EDTA produced significant reduction in the adhesion of isolates to HT29 cells, suggesting a proteic nature for both molecules involved. The surface hydrophobicity levels did not correspond with the adherence properties demonstrated, suggesting selectivity in the adhesion. There was no correlation between adherence properties and the sources of isolates; consequently, it was not possible to propose them as virulence markers.
Only two B. fragilis isolates from intestinal infections expressed fragilysin, and there was complete correlation between phenotypic (HT29) and genotypic (PCR) methods of detection. The PCR assay proved to be a good methodological choice for fragilysin detection, due to its speed and ease of reading. The evaluation of enterotoxin activity by rabbit ligated intestinal loop assay was successful; however, some authors do not recommend this experimental animal model, because it is less sensitive than the lamb ligated intestinal loop P O I *
The fragilysin molecule was characterised as a zincmetalloprotease [ 81 that induces alterations in the intestinal epithelial cells, mainly in the tight junction proteins with disruption of the epithelial barrier [2 11 . The histological responses suggest a role for fragilysin as a factor that could act in the initial stages of nonintestinal infectious processes caused by B. fragilis. Kato et al. [lo] proposed that enterotoxigenic B. fragilis (ETBF) was preferentially associated with bacteraemia. It has also been shown that the presence of the toxin increased the internalisation of enteric bacteria, such as Salmonella typhimurium and E. coli by HT29 cells [22] , leading to the belief that fragilysin may contribute to the disruption of the barrier against non-intestinal infections. In the present study, the isolates from invasive infections did not produce fragilysin, as would be expected. There was a correlation between isolates from intestinal infections and the presence of fragilysin. Mundy and Sears [23] also found a small number of ETBF in non-intestinal infections. Thus, it seems too early to suggest this protease as a determinant factor of B. fragilis invasiveness, and more studies are needed.
